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Abstract
Background: This study aimed to identify the transmission pattern of hepatitis A (HA) infection based on a primary dataset
from the Brazilian National Hepatitis Survey in a pre-vaccination context. The national survey conducted in urban areas
disclosed two epidemiological scenarios with low and intermediate HA endemicity.
Methods: A catalytic model of HA transmission was built based on a national seroprevalence survey (2005 to 2009). The
seroprevalence data from 7,062 individuals aged 5–69 years from all the Brazilian macro-regions were included. We built up
three models: fully homogeneous mixing model, with constant contact pattern; the highly assortative model and the highly
assortative model with the additional component accounting for contacts with infected food/water. Curves of prevalence,
force of infection (FOI) and the number of new infections with 99% confidence intervals (CIs) were compared between the
intermediate (North, Northeast, Midwest and Federal District) and low (South and Southeast) endemicity areas. A contour
plot was also constructed.
Results: The anti- HAV IgG seroprevalence was 68.8% (95% CI, 64.8%–72.5%) and 33.7% (95% CI, 32.4%–35.1%) for the
intermediate and low endemicity areas, respectively, according to the field data analysis. The models showed that a higher
force of infection was identified in the 10- to 19-year-old age cohort (,9,000 infected individuals per year per 100,000
susceptible persons) in the intermediate endemicity area, whereas a higher force of infection occurred in the 15- to 29-year-
old age cohort (,6,000 infected individuals per year per 100,000 susceptible persons) for the other macro-regions.
Conclusion: Our findings support the shift of Brazil toward intermediate and low endemicity levels with the shift of the risk
of infection to older age groups. These estimates of HA force of infection stratified by age and endemicity levels are useful
information to characterize the pre-vaccination scenario in Brazil.
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Introduction
The World Health Organisation (WHO) estimated approxi-
mately 126 million clinical cases of hepatitis A (HA) worldwide in
2005 [1]. Hepatitis A virus is mainly transmitted via the faecal/
oral route by either ingestion of contaminated food or water or
direct contact with an infected person [1]. Jaundice is one of the
most characteristic clinical signs of the disease and can be
accompanied by malaise, fatigue, anorexia and abdominal pain.
There is a diversity of age patterns in the disease distribution and
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severity of illness, closely related to socioeconomic conditions.
Viral exposure at an early age usually elicits an asymptomatic or
self-limiting liver infection, with resulting life-long protective
immunity. In contrast, later viral exposure occurring in adoles-
cents and adults, which takes place in more developed settings,
may cause symptomatic acute cases with increased severity and
higher disease burden [1,2]. Improving sanitation and living
conditions can reduce HA infection rates, but an effective HA
vaccine has also been available as a control strategy since the late
1990s [3,4].
The vaccination policy against the HA virus (HAV) varies
according to epidemiologic context. The World Health Organi-
zation (WHO) recommends universal vaccination against hepatitis
A in countries with intermediate and low endemicity after cost-
effectiveness analysis [1]. In South America, Argentina has
implemented one-dose routine childhood vaccination with impact
in the incidence of the disease [3].
Since the 90’s seroprevalence studies have suggested epidemi-
ological shift of HAV infection from high towards intermediate
endemicity levels in Latin American [5,6]. Nevertheless, preva-
lence close to 90% among adolescent and adults were found in and
isolated communities in the North and Central West parts of
Brazil [7–10].
In Brazil, HAV vaccination is recommended only for patients
at risk of severe illness, such as those with chronic liver diseases,
coagulopathy, haemoglobinpathy, cystic fibrosis, persons aged #
13 years with HIV infection and carriers of Hepatitis B and C
virus [11]. The first National Hepatitis Survey (2005–2009)
conducted in a representative sample of individuals aged 5–
19 years revealed the seroprevalence of HA infection to be
approximately 40% in Northeast and Midwest macro-regions of
Brazil [12]. The results of the survey showed robust evidence of
a transition from high to lower endemicity nationwide. In the
context of this transition, the highest prevalence of viral
exposure, and consequently the highest incidence of HA,
tended to shift from children to older age groups before the
introduction of routine HA vaccinations. At the population
level, the rising proportion of susceptible adults increases the
severity and economic burden of the illness [13,14].
Incidence estimates and the ratio of asymptomatic to symp-
tomatic infection by age group have important public health
implications in understanding HA transmission [15]. In addition,
estimates of the incidence rates of HA by age group over time are
essential parameters for evaluating the impact of interventions
caused by sanitation improvement and/or vaccination implemen-
tation [16,17]. In Brazil, a few HA incidence studies using
serosurvey data have shown a higher force of infection in poorer
neighbourhoods in the municipality of Rio de Janeiro in the 90s
[18–20]. These studies were conducted 20 years ago in restricted
geographical areas; thus, there was a need to estimate the force of
infection using the recent prevalence of HAV data for the entire
country available in the National Survey. Brazil has undergone
improvements in socio-economic conditions in the last two
decades. Overall there was a reduction of the Gini coefficient in
the Brazilian metropolitan areas from 0.64 (1991) to 0.49 in 2009.
The improvement of water supply, sanitation, hygiene and living
condition in general has been registered in the country. The
change in these key determinants of health status were behind the
decrease in infant mortality, diarrhoea disease, and decrease in
prevalence of HVA infection [21,22]. Consequently, the reassess-
ment of HAV strategies is essential. In a previous paper, using data
from the urban populations of the Northeast and Midwest macro-
regions of Brazil, the age-specific distribution of the population
aged 5–19 years that was susceptible to HAV infection was
estimated using a simple catalytic model to estimate the force of
infection. We showed that HA infection was closely associated
with social deprivation, considering individual and contextual
factors in a multilevel analysis [12].
This study aimed to identify the transmission pattern of HA
infection using a catalytic model based on a primary dataset from
the National Hepatitis Survey in a pre-vaccination epidemiological
context. We also discuss the methodological issues related to
evaluating the impact of the routine implementation of universal
childhood HA vaccination at the population level. To our
knowledge, this is the first HA transmission model comparing
Brazilian macro-regions in the pre-vaccination era.
Materials and Methods
Study population and setting
The Brazilian population of approximately 190 million indi-
viduals is administratively subdivided into 26 states and a Federal
District. These administrative units are congregated into five
macro-regions (Figure 1). Socioeconomic conditions and sanitary
facilities vary greatly across macro-regions, particularly between
the more developed macro-regions (South and Southeast) and the
less developed macro-regions (North, Northeast, Midwest) of the
country [23].
The mathematical model used to estimate the force of
infection was built based on primary data of HAV infection
from the National Seroprevalence Survey (2005–2009) stratified
by age and macro-region [24]. The detailed methodology of this
survey has been previously published [25]. Briefly, a household
survey aiming to assess the seroprevalence of HAV antibodies
among individuals aged 5–19 years was conducted in all 26
Brazilian state capitals and in the Federal District from 2005 to
2009 [12,25]. A multi-stage cluster sampling scheme was
applied based on the Brazilian population as determined by
the year 2000 census [23] and stratified by two age groups (5–
9 years and 10–19 years). This sampling was considered
representative of the population aged 5–19 years in the
ensemble of state capitals of each macro-region. The national
hepatitis survey was also designed to screen individuals aged
10–69 years for HBV and hepatitis C virus (HCV) antibodies.
Figure 1 shows the geographic locations and the population size
of the Brazilian macro-regions, the locations of the state capitals
and the prevalence of HA in the 5 to 19-year-old age cohort
[24].
Of the 6,468 children and young adults screened for anti-HAV
antibodies, the estimated seroprevalence ranged from 20% to 30%
depending on the macro-region. Two distinct epidemiological
patterns emerged: an intermediate endemicity area pattern (North,
Northeast and Midwest macro-regions and the Federal District)
and a low endemicity area pattern (South and Southeast macro-
regions) [12,24]. The curves of individuals susceptible to HA
infection by age were not stable by the age of 19 years that is the
curves did not reach the plateau [12]. To extend these curves up to
the older age groups, a subgroup of the survey’s participants aged
20–69 years (n = 594) from low and intermediate endemicity areas
was screened for anti-HAV antibodies, taking advantage of the
stored serum samples from the national hepatitis survey. We
randomly drew a sample of participants aged 20–69 years old
from the intermediate and from the low HAV endemicity areas;
the blood samples had been collected as part of the nationwide
survey of hepatitis B and C infection. All samples were drawn from
urban residents (25).
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Data analysis
Descriptive statistics. The estimates of overall prevalence
and prevalence by age group and 95% CI were calculated
according to the endemicity levels. The frequency of icteric cases
among the newly infected individuals was calculated by consid-
ering the previously published probabilities of developing jaundice
(icteric cases) by age groups (,1 and 1–4 years, 7.20%; 5–9 years,
37.10%; 10–19 years, 70.70%; 20–70 years, 85.20%) [26].
Estimating the epidemiological parameters
In this model, the seroprevalence data (n = 7,062) from
individuals aged 5–69 years residing in intermediate and low
endemicity areas were considered.
Let Sz(a) be the proportion of seropositive individuals for HA
(according to a positive serological test indicating previous
infection) with ages between a and azda. An estimate of the
function Sz(a) resulted from fitting the serological data to [27]
Sz(a)~1{ exp
k1
k22
k2az1ð Þ e{k2a{1
  
, ð1Þ
where k1 and k2 are the fitting parameters estimated by the
maximum likelihood method for both regions [19].
In the absence of vaccination, the force of infection l0(a) was
estimated from the seroprevalence data using the catalytic
Figure 1. The Brazilian and National Hepatitis Survey populations and the Brazilian macro-regions according to their HA
endemicity levels.
doi:10.1371/journal.pone.0094622.g001
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approach [28] according to the following formula:
l0(a)~
1
1{Sz(a)
dSz(a)
da
: ð2Þ
From equations (1) and (2), we obtain
l0(a)~k1 a e
{k2 a: ð3Þ
The seroprevalence data is related to the transmission pattern in
the population. To estimate the contact function, b(a, a’), defined
as the number of contacts a person with age a makes with persons
with age a’ per unit time, we have chosen the following patterns:
1. fully homogeneous mixing model, where the force of infection
is the same for all age classes:
b(a, a’)~b0, ð4Þ
2. Assortative model
b(a, a’)~b1(aza’)e{b2(aza’)e{(a’{a)
2=½b3zb4(aza’)2ema , ð5Þ
where m is the mortality rate and b1, b2, b3 and b4 are fitting
parameters. This function is the product of a bell-shaped curve
for the transversal profile and a positively skewed function that
resembles the force of infection given by Equation (3) for the
longitudinal profile and is based on the assumption that there is
greater interpersonal contact among people of the same age
[27,29].
3. Assortative model plus an additional component, homogeneous
by age, accounting for contacts with infected food and water.
b(a, a’)~b1(aza’)e{b2(aza’)e{(a’{a)
2=½b3zb4(aza’)2emazb5,ð6Þ
where b5 is a constant that gives the infective contact with food
and water.
In order to compare the fitting performance of the three models
mentioned above we used the Akaike Information Criterion (AIC)
[30], calculating the relative likelihood (RLi) of model i as
e(AICmin{AICi)=2, where AICmin is the minimum .of the AIC values
for the different models.
We used a Susceptible-Infected-Recovered (SIR) compartmen-
tal model [27,31]. The parameters of the contact functions b(a, a’)
were estimated so that the resulting force of infection, l(a), in the
absence of vaccination [27],
l(a)~
ðL
0
da0 b(a,a0)
ða0
0
da00 e{c(a
0{a00)l(a00) exp {
ða00
0
dz l(z)
" #
agreed with the l0(a) given by Equation (3). To estimate the
parameters of b(a, a’) we considered the values of l0(a) for the 8
age intervals in Table 1.
The derivation of the previous equation comes from the solution
of an age-dependent SIR model in the steady-state condition. A
more detailed description of both the mathematical derivation of
l(a) and the numerical solution to estimate the parameters of
b(a, a’) may be found in another publication [27].
Note that, using the procedure described above, the parameters
of the contact function are obtained from the seroprevalence data.
The fitted contact function may be used, for instance, in models
that assess the effects of vaccination programs.
The mortality rate was estimated as the inverse of the life
expectancy at birth, taken as m~0:0135 yr21 (life expectancy of
74 years) for the low endemicity areas (South, Southeast) and
m~0:0139 yr21 (life expectancy of 72 years) for the intermediate
endemicity areas (North, Northeast, Midwest and Federal
District).
The recovery rate c was designated as 8.1 years21, correspond-
ing to an infectious period of 45 days.
From the force of infection, we can define the average age at
which susceptible persons acquire infection using the following
Figure 2. Seroprevalence fitted curves of HA infection (solid
lines) for the intermediate (x2 = 6.7, p = 0.349) and low
endemicity (x2 =85.5, p ,0.001) areas (A), the corresponding
99% CIs (red dotted and blue dashed lines, respectively), and
95% confidence intervals for the observed data (error bars); (B)
Seroprevalence ratio of HA infection between the intermediate
and low endemicity areas by age (solid line) and its corre-
sponding 99% CI (dashed lines). A value of 1 denotes an equal
prevalence in both areas, an integer.1 indicates a higher prevalence in
the intermediate endemicity area, and a value ,1 indicates a higher
prevalence in the low endemicity area. The fitting parameters were:
k1~(0:01762+0:00096) year
22 and k1~(0:0699+0:0048) year
21 for
the intermediate endemicity area and k1~(0:00815+0:00018) year
22
and k1~(0:0485+0:0031) year
21 for the low endemicity area.
doi:10.1371/journal.pone.0094622.g002
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formula:
a~
Ð L
0
al(a)s(a)daÐ L
0
l(a)s(a)da
: ð7Þ
where s(a), the proportion of remaining susceptible individuals,
may be approximated by 1{Sz(a).
We have taken the highest age observed in the sero-
epidemiological survey (L~70 years) as the upper integration
limit of the integrals of the equation (7).
The average force of infection was estimated using the definition
proposed by Yu et al. [29]
l~
Ð L
0
l(a)s(a)daÐ L
0
s(a)da
:
In the steady state preceding vaccination, the proportion of new
infections between ages ai and af may be calculated using the
following formula [32]:
Y(½ai,af )~Sz(ai){Sz(af ): ð8Þ
Monte Carlo simulations
To compare the seroprevalence fitted curves for the North and
South regions and the corresponding force of infection curves, we
used Monte Carlo simulations to generate CIs for the curves based
on the approach proposed by Amaku et al. [33]. In this case, the
Monte Carlo method is a straightforward and accurate alternative
for estimating CIs because the fitted parameters for the
seroprevalence functions and the corresponding covariance
matrices are available. Analytical estimates for the CIs would be
more complicated to derive and would provide results with
presumably small numerical differences if compared to the Monte
Carlo simulations.
The variance-covariance matrix V for the seroprevalence
function parameters (equation [1]),
V~
s2k1 cov(k1, k2)
cov(k1, k2) s
2
k2
 !
, ð9Þ
was estimated from the fitting procedure. In matrix V,
s2ki (i~1, 2) is the variance of parameter ki (i~1, 2), and
cov(k1, k2) is the covariance between the two parameters.
From the estimated variance-covariance matrix V, the Monte
Carlo algorithm randomly generates 1,000 pairs of values (k1, k2)
and then calculates CIs for the fitted curves. More details on how
this algorithm works may be found in Amaku et al. [33]. We have
Figure 3. Force of HA infection by age (A), as estimated by the catalytic approach, for the intermediate and low endemicity areas
(solid lines) and the corresponding 99% CIs for the curves (red dotted lines for the intermediate endemicity area and blue dashed
lines for the low endemicity area). (B) Hepatitis A force of infection curves by age and the ratio between the intermediate and low endemicity
areas for the North region (solid line) and its corresponding 99% CI (dashed lines). A value of 1 denotes an equal number of new infected individuals
per year in both areas, an integer.1 indicates a higher number of new infected individuals per year in the intermediate endemicity area, and a value
,1 indicates a higher number of infected individuals in the low endemicity area. (C) Proportion of new hepatitis A infections for the intermediate and
low endemicity regions (red and blue solid lines, respectively) and the corresponding 99% CIs (dotted and dashed lines, respectively). (D) HA
incidence ratio (solid line) between the intermediate and low endemicity areas by age and its 99% CI (dashed lines).
doi:10.1371/journal.pone.0094622.g003
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implemented the computational routines using the R statistical
software, version 2.10 (Institute for Statistics and Mathematics,
Vienna, Austria) [34].
After estimating the CIs of the seroprevalence curves for the
North and South regions, we calculated the ratio between the
randomly generated values (within the CIs) for the North and
South regions for a given age. If the 100(1-a)% CI for this ratio
does not include 1, it means that for that specific age, there is a
significant difference between the two compared curves at a level
of significance a.
Ethical issues
Written consent was obtained from all participants or, in the
case of minors, from their legal guardians. The project was
submitted and approved by the National Research Ethics
Committee (CONEP) of the Brazilian National Health Council
and by the local research ethics committees at each site.
Results
Figure 2A shows the seroprevalence fitted curves for the North-
Northeast-Midwest macro-regions and the Federal District (i.e.,
intermediate HAV endemicity area) and the South-Southeast
macro-regions (i.e., low endemicity area), as well as the
corresponding 99% confidence intervals estimated in the Monte
Carlo simulations. For both areas, the observed prevalence of HA
increased with increasing age, but the curve for the North-
Northeast-Midwest macro-region reached the plateau at an earlier
age (,30 years) than the curve for the South and Southeast
macro-regions. The ratio between the intermediate and low
endemicity seroprevalence curves is shown in Figure 2B. We
observed that from the age of 45 years (approximately) onward,
the lower limit of the 99% CI includes 1; that is, the estimated
prevalence was similar for both endemicity areas.
The mean age of infection was 13.8 years (95% CI, 12.8–14.7)
in the intermediate endemicity areas and 19.4 years (95% CI,
18.7–19.9) in the low endemicity areas. The force of infection
curves, predicted using the catalytic approach defined in equations
(2) and (3), are shown in Figure 3A with their corresponding 99%
CIs. There is an overlap between the CIs for ages older than
20 years when the lower limit of the 99% CI for the force of
infection ratio becomes lower than 1 (Figure 3B). Figure 3C
depicts the estimates for the proportion of new infections (equation
[6]) in the absence of vaccinations for the North-Northeast-
Midwest and South-Southeast macro-region considering 1-year
age intervals in the equation (8). In Figure 3D, we show the
corresponding incidence ratio, which is ,1 from the age of
15 years, indicating that the predicted incidence was higher at an
earlier age in the North-Northeast-Midwest macro-regions than in
the South-Southeast macro-regions.
The predicted contact functions, b(a, a’), for the intermediate
and low endemicity areas are shown in Figure 4. Note that the
intensity of transmission is higher in the intermediate endemicity
areas. It should be highlighted that differences between models are
hardly noticed by visual inspection.
Table 1 summarises the observed prevalence of HA infection, the
predicted force of infection, the predicted number of newly infected
individuals and the estimated number of icteric cases by age group
and stratified by endemicity levels. The overall age-adjusted HA
prevalence was 68.8% (95% CI, 64.8%–72.5%) and 33.7% (95%
CI, 32.4%–35.1%) in the intermediate and low endemicity areas,
respectively. In the intermediate endemicity area the prevalence was
32.9% in the 5–9 years old age group and in the low endemicity it
was 19.88% in the same age-group. In the intermediate endemicity
areas, the peak force of infection was identified in the 10- to 19-year-
old age group (,9,000 infected individuals per year per 100,000
susceptible persons), whereas the peak force of infection occurred in
the 15- to 29-year-old age group (,6,000 infected individuals per
year per 100,000 susceptible persons) for the other macro-regions.
The estimated number of icteric cases was 806,452 in the
intermediate HAV endemicity areas, of which 52% were younger
than 15 years old, while in the low endemicity areas, the estimated
number of icteric cases was 1,061,785, of which 32% were younger
than 15 years old.
The age at midpoint of population susceptibility, defined as the
age at which half of the population in that age group does not have
anti-HAV IgG antibodies, was 11.5 and 17 years, respectively, for
the intermediate and low HAV endemicity areas.
Table 2 shows the results of AIC for the three contact functions.
It can be noticed that assortative model has the minimum AIC
value and therefore is the model that minimizes the estimated
information loss.
Figure 4. The contact function b(a, a’) and the respective
contour plot for the intermediate (A, assortative; C, assortative
with food and water transmission) and low (B, assortative; D,
assortative with food and water transmission) endemicity
areas. The fitted parameters were: (A) b1~0:0860 year
22, b2~0:0397
year21, b3~10:6 year and b4~0:34; (B) b1~0:0442 year
22, b2~0:0304
year21, b3~8:1 year and b4~0:42; (C) b1~0:097 year
22, b2~0:0412
year21, b3~8:0 year, b4~0:45 and b5~{0:07 year
21; (D) b1~0:061
year22, b2~0:034 year
21, b3~7:9 year, b4~0:64 and b5~{0:16
year21; for the fully homogeneous model (not shown), b0~0:561
year21 (intermediate) and b0~0:387 year
21 (low).
doi:10.1371/journal.pone.0094622.g004
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Discussion
The mathematical modelling approach used in this work, based
on a SIR epidemic model together with a Monte Carlo method to
estimate confidence intervals for the age-dependent curves,
allowed for the comparison of the rates of HA infection by age
according to the two endemicity levels in Brazil. In the more
socioeconomically developed macroregion (South and Southeast),
considered low HAV endemicity, the age of virus exposure
occurred later compared to the intermediate endemicity areas. At
least half of the population aged 10- to 14-years-old and older was
still susceptible to HA infection in the intermediate and low
endemicity areas. The model herein predicted a gradual build-up
of new HA infections during adolescence and adulthood but with
different force of infection in both endemic settings.
A comprehensive HA survey conducted in Brazil from 2005
through 2009 showed a lower prevalence (,40%) among children
and adolescents [24] than previously reported in selected areas
[35–37]. In our preliminary modelling approach, the fitted curves
of prevalence using a dataset comprising individuals aged 5–
19 years from this national survey still presented an ascending
trend of infection in the second decade of life. Therefore, we
extended the detection of specific IgG serology for a subsample of
the adult population to build a full mathematical model that
encompassed all age strata. At the population level, the observed
prevalence of HA infection was highest at 30–39 years, as shown
by the saturation of the infection levels in the intermediate
endemicity area. Conversely, the highest observed prevalence was
achieved two decades later (50–59 years) in the low endemicity
setting. The prevalence rates were statistically higher in the
intermediate endemicity areas until the age of 45 years compared
to the low endemicity areas but similar in both areas at older ages,
as depicted by the prevalence ratio curves.
The two models, built according to the endemicity of the
Brazilian regions, yielded important information about the
difference in the force of HA infection curves by age. First, the
transmission curves showed similar shapes in both areas, skewed to
the right toward the young age groups. The risk of acquiring HA
infection was higher for children and adolescents until the age of
25 in the intermediate endemicity region, as depicted by the ratio
of the force of infection curves between regions. Our findings seem
compatible with a previous mathematical model of the USA
population, which used data from a national population serosur-
vey and estimated differences in the force of HA infection between
age groups across the different regions [17].
Although data-driven age-specific contact pattern were shown
to be an alternative route to the estimation of epidemiological
parameters [38,39], specific contact data for the two Brazilian
macro-regions are not available because no similar studies were
undertaken in Brazil.
The HA models presented herein, using the assortative model for
the contact function, were incorporated into a cost-effectiveness
analysis of HA vaccination for Brazil [40]. When using these
parameters, universal HA vaccination was shown to be cost-saving
in both endemic settings. We are aware that the presented model
simplifies HA epidemiology by primarily focusing on direct
transmission of the infection and excludes the issues related to
outbreaks and population movements between areas. Another
possible limitation of the analysis is using the serosurvey data from
an urban population that did not include rural and institutionalised
populations. Nevertheless, these models used seroprevalence data
from a representative sample of the Brazilian urban population,
which accounts for 84% of the total population of the country [41].
Additionally, the force of infection by age group could be considered
a baseline transmission parameter for the two endemicity regions.
Assuming the potential upcoming addition of the HA vaccine to
the routine immunisation schedule in Brazil, there is a need to
discuss the best methodological approach for evaluating the impact
of this intervention at the population level [42]. In general, a
decrease in the incidence of disease, as reported by surveillance
systems, is used to evaluate the protective effect of vaccination [43].
For example, in southern Italy, age-stratified case notification
analysis showed a reduction in HA case notification when comparing
the HA pre-vaccination and post-vaccination implementation
periods [44,45]. However, the usefulness of this design depends on
the quality of the HA surveillance system. In Brazil, HA cases are
generally underreported, and not all cases are laboratory confirmed
or investigated [46]. At least two issues should be considered in
evaluating HA vaccination. First, asymptomatic infections may go
undetected if case notification is the outcome measure. Second, the
serological marker of infection is the same as the HA vaccine. One
alternative would be to design repeated serosurveys of unvaccinated
people to determine the age distribution pattern of HA infection, as
is generally recommended to evaluate the immune status of a
population [20,47]. Therefore, the force of infection could be
obtained by modelling the prevalence data, which can show changes
in the force of infection trends over time after vaccination
implementation. This same strategy of using studies on the force of
infection trends derived from serosurveys was useful for evaluating
the impact of measles vaccination [48]. In addition, a serosurvey that
includes a vaccinated cohort would measure vaccination coverage
and the herd immunity effect at the population level. The temporal
trend of fatal HA cases and liver transplantation resulting from HA
infection should be monitored in the post-vaccination era to measure
the burden of the disease, as recommended by a WHO position
paper [1]. In addition to evaluating HA vaccination implementation,
studies should take into account the potential reduction of viral
transmission over time because of improvements in socioeconomic
conditions. In Brazil, the HA vaccination evaluation should
encompass the two diverse transmission patterns identified by our
study regardless of the study design adopted.
Table 2. Comparison of three models of contact function (equations 4, 5 and 6) by the Akaike Information Criterion (AIC) and the
relative likelihood (RL) of the models.
Low Endemicity Intermediate Endemicity
Model Parameters AIC RL AIC RL
Fully homogeneous 1 142.268 1.12E-26 281.491 6.56E-57
Assortative 4 22.759 1 22.757 1
Assortative + food/water transmission 5 24.705 0.378 24.707 0.377
doi:10.1371/journal.pone.0094622.t002
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Our study differs from other previous HA incidence models in
Brazil in that it (1) uses a large dataset that is representative of
urban populations and various age groups, (2) compares two
different endemicity levels, (3) has the ability to distinguish diverse
transmission patterns according to endemicity levels, (4) demon-
strates striking differences in the force of infection related to age, as
depicted by the ratio curves between the endemicity levels and (5)
demonstrates the increasing number of susceptible individuals and,
consequently, the increase in incidence in adults
Finally, our findings support the shift of Brazil toward
intermediate and low endemicity levels with the shift of the risk
of infection to older age groups. We believe that these findings of
HA force of infection stratified by age and endemicity levels might
be useful as baseline data in a pre-vaccination scenario for Brazil.
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